Andre Goy, M.D., Chairman and Director, and Chief of Lymphoma, John Theurer Cancer Center and Chief Science Officer and Director of Research and Innovation of Regional Cancer Care Associates, presented new data providing further insight into the complexity of the genomic landscape in high-risk diffuse large B-cell lymphoma (DLBCL), the most common subtype of Non-Hodgkin Lymphoma (NHL) among adults. The oral abstract was presented today during Session 622 at 3:15 p.m. in the Ernest N. Morial Convention Center at the 2013 American Society of Hematology (ASH) Annual Meeting in New Orleans, LA.
Help employers find you! Check out all the jobs and post your resume.
